4.6 Article

Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression

Bessi Qorri et al.

Summary: Drug repurposing in combination with clinical standard chemotherapeutics opens a novel and promising clinical treatment approach for patients with pancreatic cancer. The combination of aspirin and oseltamivir phosphate with chemotherapeutic gemcitabine shows a therapeutic effect on pancreatic cancer cells, modulating cell proliferation, invasion, clonogenicity, and migration.

CANCERS (2022)

Review Genetics & Heredity

Mutation-selection balance and compensatory mechanisms in tumour evolution

Erez Persi et al.

Summary: Intratumour heterogeneity and phenotypic plasticity enabled by various somatic aberrations, epigenetic and metabolic adaptations, play a crucial role in helping cancers resist treatment and survive under environmental stress. Understanding the interplay between genetic aberrations, the microenvironment, and epigenetic and metabolic cellular states is essential for early detection, prevention, and development of efficient therapeutic strategies for cancer.

NATURE REVIEWS GENETICS (2021)

Review Toxicology

Cancer drug resistance induced by EMT: novel therapeutic strategies

Javier De las Rivas et al.

Summary: This review explores the important clinical benefits achieved in cancer patients through drug-targeting strategies, but drug resistance remains a major issue. The impact of epithelial-mesenchymal plasticity and tumor microenvironment on treatment effectiveness is discussed, along with the use of bioinformatics and pharmacogenomics to study the biological effects of epithelial-to-mesenchymal transition on drug resistance and develop novel pharmacological approaches in the future.

ARCHIVES OF TOXICOLOGY (2021)

Review Cell Biology

Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family

Yoko Katsuno et al.

Summary: Epithelial cells suppress epithelial characteristics and exhibit mesenchymal traits to migrate and adapt, regulated by cooperation of various signaling pathways. TGF-beta and related proteins play key roles in directing epithelial plasticity, impacting metazoan development, wound healing, fibrosis, and cancer progression.

DEVELOPMENTAL CELL (2021)

Review Oncology

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance

Kostas Palamaris et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy characterized by aggressive behavior and resistance to chemotherapy, with emerging evidence pointing to epithelial to mesenchymal transition (EMT) as a key driver of disease progression and drug resistance. EMT allows cancer cells to transition to a more mesenchymal state, contributing to tumor dissemination and chemoresistance in PDAC.

CANCERS (2021)

Review Oncology

Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer

Tuan Luu

Summary: Pancreatic cancer, known for its high mortality and insensitivity to existing therapies, has attracted increasing scholarly attention for its progression mechanisms, particularly the role of epithelial-mesenchymal transition (EMT) in cancer genesis and metastasis. Recent discoveries on EMT-regulating factors in pancreatic cancer have shed light on the relationship between EMT and this cancer type, marking a key advancement in research on EMT in pancreatic cancer.

FRONTIERS IN ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment

Darya Javadrashid et al.

Summary: Genetic alterations, particularly the K-Ras mutation, play a major role in the progression of pancreatic precursor lesions into PDAC. The tumor microenvironment and immune evasion are challenges in therapeutic approaches, with targeting signaling molecules and immune checkpoint inhibition showing promising results in pancreatic cancer treatment.

BIOMEDICINES (2021)

Review Biochemistry & Molecular Biology

Targeting PI3K/Akt signal transduction for cancer therapy

Yan He et al.

Summary: The PI3K/Akt signaling pathway plays a crucial role in cancer, and targeting inhibitors against it may aid in drug discovery. Additionally, combining pathway inhibitors with other cancer treatment strategies could be an effective approach to solving therapeutic dilemmas.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Biochemistry & Molecular Biology

CD36 and CD97 in Pancreatic Cancer versus Other Malignancies

Cristiana Tanase et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Pathology

Aspirin inhibits hypoxia-mediated lung cancer cell sternness and exosome function

Jinghua Chen et al.

PATHOLOGY RESEARCH AND PRACTICE (2019)

Review Oncology

The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond

Silvia Pastorekova et al.

CANCER AND METASTASIS REVIEWS (2019)

Review Biochemistry & Molecular Biology

Markers of pancreatic cancer stem cells and their clinical and therapeutic implications

Arkadiusz Gzil et al.

MOLECULAR BIOLOGY REPORTS (2019)

Review Cell Biology

Biology and clinical relevance of EpCAM

Laura Keller et al.

CELL STRESS (2019)

Article Multidisciplinary Sciences

Targeting metastasis-initiating cells through the fatty acid receptor CD36

Gloria Pascual et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer

N. L. E. Harris et al.

ONCOGENE (2017)

Review Pharmacology & Pharmacy

Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies

Guan-Zhong Qiu et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2017)

Review Medicine, General & Internal

The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance

Sunjida Ahmed et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Review Biochemistry & Molecular Biology

Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer

Safieh Ebrahimi et al.

CURRENT MEDICINAL CHEMISTRY (2017)

Review Pharmacology & Pharmacy

Current Standards of Chemotherapy for Pancreatic Cancer

May Tun Saung et al.

CLINICAL THERAPEUTICS (2017)

Review Biochemistry & Molecular Biology

Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials

Ming-jie Jiang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)

Article Cell Biology

Stiffness of pancreatic cancer cells is associated with increased invasive potential

Angelyn V. Nguyen et al.

INTEGRATIVE BIOLOGY (2016)

Review Cell Biology

Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease

FuiBoon Kai et al.

TRENDS IN CELL BIOLOGY (2016)

Review Medicine, General & Internal

Role of EMT in Metastasis and Therapy Resistance

Bethany N. Smith et al.

JOURNAL OF CLINICAL MEDICINE (2016)

Article Multidisciplinary Sciences

Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance

Antonina V. Kurtova et al.

NATURE (2015)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Oncology

Cancer treatments transform residual cancer cell phenotype

William W. Harless

CANCER CELL INTERNATIONAL (2011)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Editorial Material Oncology

Novel therapies for pancreatic cancer: setbacks and progress

Han Hsi Wong et al.

FUTURE ONCOLOGY (2010)

Article Multidisciplinary Sciences

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Peter J. Campbell et al.

NATURE (2010)

Article Multidisciplinary Sciences

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Shinichi Yachida et al.

NATURE (2010)

Article Multidisciplinary Sciences

Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

Jennifer P. Morton et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Schammim R. Amith et al.

Jove-Journal of Visualized Experiments (2010)

Review Cell Biology

Roles of TGF beta in metastasis

David Padua et al.

CELL RESEARCH (2009)

Article Biochemistry & Molecular Biology

Dependence of pathogen molecule-induced Toll-like receptor activation and cell function on Neu1 sialidase

Schammim Ray Amith et al.

GLYCOCONJUGATE JOURNAL (2009)

Review Gastroenterology & Hepatology

Pancreatic cancer: molecular pathogenesis and new therapeutic targets

Han H. Wong et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)

Review Pathology

Pancreatic cancer

Anirban Maitra et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)

Article Biochemistry & Molecular Biology

The epithelial-mesenchymal transition generates cells with properties of stem cells

Sendurai A. Mani et al.

Review Oncology

Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis

Christine E. Eyler et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Multidisciplinary Sciences

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

John P. Chute et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Cell Biology

Complex networks orchestrate epithelial-mesenchymal transitions

JP Thiery et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)